119 related articles for article (PubMed ID: 22039842)
1. Association between apolipoprotein E-polymorphism and Ischemic heart disease patients with or without type 2 diabetes mellitus: a preliminary study in Kuwait.
Al-Majed HT; Qasem JA; Al-Sherifi AK; Al-Attar AA; Qasem AA; Abdullah SA
Arch Iran Med; 2011 Nov; 14(6):385-8. PubMed ID: 22039842
[TBL] [Abstract][Full Text] [Related]
2. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
Duman BS; Oztürk M; Yilmazer S; Hatemi H
Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
[TBL] [Abstract][Full Text] [Related]
4. Relationship between severity of coronary artery disease and apolipoprotein E gene polymorphism.
Arslan Ince FD; Atay A; Köseoğlu M; Yeşil M; Deveci E
Anadolu Kardiyol Derg; 2010 Jun; 10(3):202-8. PubMed ID: 20538553
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
[TBL] [Abstract][Full Text] [Related]
7. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E polymorphism in type 2 diabetic patients of Talca, Chile.
Leiva E; Mujica V; Orrego R; Prieto M; Arredondo M
Diabetes Res Clin Pract; 2005 Jun; 68(3):244-9. PubMed ID: 15936467
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction: case-control study in a large population sample.
Koch W; Hoppmann P; Schömig A; Kastrati A
Int J Cardiol; 2008 Mar; 125(1):116-7. PubMed ID: 17433475
[TBL] [Abstract][Full Text] [Related]
10. [APOE gene polymorphisms associated with Down syndrome in Colombian populations].
Rengifo L; Gaviria D; Serrano H
Biomedica; 2012 Jun; 32(2):224-32. PubMed ID: 23242296
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E gene polymorphism and previous alcohol withdrawal seizures.
Wilhelm J; von Ahsen N; Hillemacher T; Bayerlein K; Frieling H; Kornhuber J; Bleich S
J Psychiatr Res; 2007 Nov; 41(10):871-5. PubMed ID: 16959267
[TBL] [Abstract][Full Text] [Related]
13. The relationship of the apolipoprotein E gene polymorphism in Turkish Type 2 Diabetic Patients with and without diabetic foot ulcers.
Mehmet E; Zuhal E; Mustafa K; Soner S; Aslı T; Sevki C
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S30-3. PubMed ID: 26476487
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients.
Leiva E; Mujica V; Elematore I; Orrego R; Díaz G; Prieto M; Arredondo M
Diabetes Res Clin Pract; 2007 Nov; 78(2):196-201. PubMed ID: 17481771
[TBL] [Abstract][Full Text] [Related]
15. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
[TBL] [Abstract][Full Text] [Related]
16. Association between apoliprotein E gene polymorphism and hypercholesterolemic phenotype in Maracaibo, Zulia state, Venezuela.
Arráiz N; Bermúdez V; Prieto C; Sánchez MP; Escalona C; Sanz E; Rondón N; Reyes F; Velasco M
Am J Ther; 2010; 17(3):330-6. PubMed ID: 20019593
[TBL] [Abstract][Full Text] [Related]
17. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism in diabetic and non-diabetic patients: does it really contribute to atherosclerosis?
Camsari A; Tamer L; Aras Ateş N; Pekdemir H; Ciçek D; Ercan B; Camdeviren H; Atik U
Acta Cardiol; 2005 Aug; 60(4):409-14. PubMed ID: 16128374
[TBL] [Abstract][Full Text] [Related]
19. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes.
Tien KJ; Tu ST; Chou CW; Yang CY; Hsiao JY; Shin SJ; Chen HC; Hsieh MC
Am J Nephrol; 2011; 33(3):231-8. PubMed ID: 21346330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
